Alexandria Real Estate Equities, Inc. (ARE)
Alexandria Stock Soars 10.9% in a Month: Will the Trend Continue?
ARE shares jump 10.9% in a month as leasing strength, Megacampus exposure and $4.17B liquidity support cash flow amid uneven demand.
Alexandria Or Healthpeak? Your Risk Tolerance May Determine The Winner
Healthpeak Properties offers a diversified, growth-oriented REIT portfolio with 40% life science exposure and robust 2026 FFO guidance of $1.71–$1.75 per share. DOC maintains conservative 37.3% leverage, investment-grade ratings with a stable outlook, and a well-covered 6.2% monthly dividend supported by a 70% payout ratio. Alexandria Real Estate is in portfolio contraction mode, facing sector oversupply and negative re-leasing spreads, with 2026 FFO guidance annualized at $5.80 per share.
Alexandria Real Estate: Thesis Has Evolved, Same Hold, Different Goalposts
Alexandria Real Estate Equities remains rated Hold as improved policy clarity and a recovering disposition market are offset by new operational headwinds. NIH indirect cost cap removal and better asset sale prospects reduce tail risks, but occupancy and NOI guidance have been revised downward amid weak leasing trends. A significant 2027 lease expiration wall (~$97m annual rent) now threatens to extend FFO pressures beyond Q4 2026, clouding recovery visibility.
Why Is Alexandria Real Estate Equities (ARE) Up 20% Since Last Earnings Report?
Alexandria Real Estate Equities (ARE) reported earnings 30 days ago. What's next for the stock?
Implied Volatility Surging for Alexandria Real Estate Equities Stock Options
Investors need to pay close attention to ARE stock based on the movements in the options market lately.
The Most Undervalued REITs I Am Buying Right Now
Some of the cheapest REITs are in sectors hit by temporary oversupply. Storage and life science stand out as especially discounted today. Patient investors may find rare long-term upside in the selloff.
Alexandria Real Estate: Decade Low, Deep-Value Play Or Value Trap - I Say Both
Alexandria Real Estate Equities faces persistent headwinds, with Q1 earnings revealing a 25% FFO decline and occupancy dropping to 87.7%. ARE's deteriorating leasing conditions, high leverage (net debt/EBITDA at 6.8x), and negative spreads raise the risk of another dividend cut within 6–12 months. Despite a forward multiple of just 6.43x and a 7%+ yield, ongoing sectoral and macroeconomic challenges limit near-term upside; shares are likely range-bound at $40–$45.
Alexandria Real Estate: Red Pill Blue Pill
Alexandria Real Estate Equities met FFO estimates this morning. The stock still tanked 11%. We tell you why.
ARE Q1 FFO Matches Estimates, Revenues Top on Tenant Collections
ARE meets Q1 FFO estimates as leasing stays active and liquidity remains strong despite revenue decline and occupancy pressure.
Alexandria Real Estate Equities (ARE) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Alexandria Real Estate Equities (ARE) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Alexandria Real Estate Equities (ARE) Meets Q1 FFO Estimates
Alexandria Real Estate Equities (ARE) came out with quarterly funds from operations (FFO) of $1.73 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $2.3 per share a year ago.
Unveiling Alexandria Real Estate Equities (ARE) Q1 Outlook: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Alexandria Real Estate Equities (ARE) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
